Company Filing History:
Years Active: 2015-2017
Title: The Innovative Path of Marie Foegh
Introduction
Marie Foegh, a prominent inventor based in Cresskill, NJ, has made significant contributions to the field of pharmaceutical innovation with a focus on transdermal delivery systems. With a remarkable portfolio of eight patents, her work stands out for its potential impact on hormone delivery methods.
Latest Patents
Marie Foegh's latest patents include groundbreaking advancements in transdermal contraceptive hormone delivery. These patents detail innovative dosing regimens that optimize the administration of hormones through the skin. Specifically, she has developed a dosing regimen comprising a variable treatment cycle and a variable rest interval, as well as an alternative regimen that follows a 28-day treatment cycle with fixed treatment and rest intervals. These innovations aim to enhance patient adherence and improve therapeutic outcomes.
Career Highlights
Throughout her career, Marie has demonstrated a commitment to improving healthcare solutions. Her work at Agile Therapeutics, Inc. has positioned her at the forefront of hormone therapy research. By addressing critical challenges in hormone delivery, she has paved the way for more effective contraceptive options, thereby greatly influencing women's health.
Collaborations
Marie Foegh has worked alongside esteemed colleagues such as Thomas M. Rossi and Agis F. Kydonieus. Their collaborative efforts have been instrumental in advancing research and development in transdermal technologies. This teamwork has allowed for a comprehensive approach to tackling complex issues surrounding hormone delivery systems.
Conclusion
Marie Foegh's dedication to innovation and her impressive patent portfolio reflect her significant contributions to the field of pharmaceuticals. Her work not only showcases her inventive spirit but also highlights the importance of collaboration in driving progress within the industry. As she continues to work in the dynamic environment of Agile Therapeutics, Inc., her future endeavors are sure to push the boundaries of what is possible in transdermal delivery systems.